The use of ion exchange resins for the estimation of HbA le in clinical samples rests on the assumption that HbA le is effectively and efficiently separated from other N-terminally modified haemoglobins and from HbA o ' To test this assumption, we applied highly purified preparations of HbA 1a + Ib' HbA le and HbA o to ion exchange rninicolumns, using conditions of application simulating actual blood samples and the first and second elution buffers provided by the manufacturer. The authenticity and purity of the applied haemoglobin preparations were documented by high performance liquid chromatography, gel electrophoresis and carbohydrate content. About 400/0 of the applied HbA la + Ib eluted in the first fraction; 45% eluted in the second fraction, and 10% to 15% required I mollL NaCI to elute from the column. Of the applied HbA 1e, 65-80% eluted where expected in the second fraction, about 20% required I mollL NaCI to elute from the column, and the remainder eluted with HbA 1a + Ib ' Some 3-6% of pure HbA o applied to minicolumns emerged in the second fraction, with the remainder eluting as expected after making the buffer 1 mollL in NaC!. The results indicate that the fraction eluting from ion exchange minicolumn chromatography that is designated 'HbA le' contains HbA 1a + l b s and that a substantial portion of the HbA le in an applied sample does not elute in this fraction.
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Measurement of glycated haemoglobin has become incorporated into the clinical armamentarium as an objective parameter to assess integrated long-term glycemic control in diabetic patients. 1-6 The recognized importance of this parameter has resulted in a variety of methods for measurement of total glycohaemoglobin or haemoglobin Ale, most of which rely on one or the other of two methodologic principles: the ability of phenylboronate in alkaline solution to complex with cis-diol groups of sugars (total glycohaemoglobin): or the change in charge properties, detectable with ion exchange chromatography or electrophoresis, resulting from the modification of N-terminal valine residues of the~-chain (HbA 1e). Published studies establishing that N-terminal modification of haemoglobin alters its isoelectric point and, hence, elution characteristics from cation exchange and other Correspondence: Dr Margo P Cohen. resmst'? led to the development of HbA le assay by ion exchange chromatography on minicolumns.'! These assays, and mini columns for estimation of total glycohaemoglobin by phenylboronate affinity chromatography'v'" are now widely used, although many laboratories continue to employ electrophoresisIS or have implemented high-performance liquid chromatography (HPLC) procedures" for HhAj, determination. Fundamental to the validity of results obtained with any of these methods is the correctness of the analytic principle involved and the separatory adequacy of the methodologic procedure. The Bio-Rad minicolumn HbA le assay claims that only HbA la and HbA lb elute with the low ionic strength buffer supplied by the manufacturer, that HbA le elutes with the second (higher ionic strength) buffer that is supplied, and that HbA o does not elute with either of these buffers."? However, this assertion has not been rigorously tested with purified preparations of the various haemoglobin species. While it is appreciated that HbF has ion exchange binding characteristics similar to HbA le and will contribute to the HbA le value if present, and that N-terminally modified variant haemoglobins such as HbS and HbC that bind more tightly than does HbA le will produce lowered values, there is little information on the elution of purified HbA 1a + lb' HbA le and HbA o with the low ionic strength and second, higher ionic strength buffers supplied with this assay. One study suggested that 200/0 of the HbA le is not collected in the Ale peak and that the fraction collected for the HbA 1e includes 12% of the HbA 1a + lb material" but, since whole blood was applied, the nature of the material in these 'shoulders' was unidentified.
In the present study, we applied highly purified preparations of HbA 1a + lb s HbA le, and HbA o to commercially available minicolumns, using conditions of application simulating those of actual blood samples, eluting the haemoglobin components with the first and second elution buffers supplied by the manufacturer, and then making the columns 1 mollL in NaCI to elute remaining haemoglobin.
MATERIALS AND METHODS
N-terminally modified haemoglobins and haemoglobin A o were purified from Iysates of human erythrocytes by ion exchange chromatography on at least three sequential columns l, 19,20. In brief, a column of Bio-Rex 70 was equilibrated with 0·05 mollL potassium phosphate buffer, pH 6· 5, containing O' 01 mollL KCN and 0'015 mollL NaCI. Fast moving haemoglobins modified at the N-terminal position (HbA la, Alb and Ale) elute under these conditions. Haemoglobin A o was then eluted by making the buffer 1 mollL in NaC!. The fast moving peak is dialysed against O' 05 mollL potassium phosphate, pH 6' 6 and is reapplied to a Bio-Rex 70 column equilibated with the same buffer, and then eluted with a linear salt gradient (0'00-0'10 mollL NaCl) for further separation of HbA la + Alb and for purification of HbA le. The fractions containing HbA le are reapplied to the column and eluted as a homogeneous peak with the 0·00-0'10 mollL NaCI gradient. Aliquots of individual fractions collected from the ion exchange columns were monitored with HPLC (see be/ow) to ensure adequacy of separation, and the purity of the final prep-Ann Clin Biochem 1993: 30 arations was corroborated with HPLC, gel electrophoresis, and determination of glucose in ketoamine linkage.
Analysis of the purified haemoglobins was performed on a Waters HPLC packed with SP-5PW resin (Waters; Milford, MA, USA). This is a cationic exchange resin in which a sulfopropyl group is introduced onto a 10 p. hydrophilic rigid resin. The HPLC column was pre-equilibrated with 96% Buffer A (0' 0124mol/L NaH 2P04 ; 0'0032mo1/L KCN; 10% acetonitrile [v/v] added to each litre of buffer; pH titrated to 7· 0) and 4% Buffer B (0' 12 mol/L NaH 2P04 ; 10% acetonitrile [v/v] added to each litre of buffer; pH titrated to 6' 54) and run at a flow rate of 1· 2 mL/min for a total of 16 min. The elution was programmed to change the ratios of Buffer A to Buffer B from 96/4 at time 0 to 70/30 at 5 min, 30170 at 10 min, and 01100 at 11 min. \9 Gel electrophoresis was performed on Corning citrate agarose gels for 35 min at 90V in O' 1 mollL sodium citrate, pH 6· 2. The amount of glucose in ketoamine linkage was determined by assaying aliquots for haemoglobin (Sigma Chemical Co.) and for hydroxymethylfurfuraldehyde (HMF) formed upon reaction with thiobarbituric acid. 21, 22 Aliquots of the HbAla+ l b s HbA le or HhA, preparations, which were extensively dialysed against water and concentrated, were applied to individual minicolumns of cation exchange resin (Bio-Rad Laboratories; Hercules, CA, USA) according to the protocol provided by the manufacturer. For application, the haemoglobin solutions were brought to 100 p.L volume with the Bio-Rad preparation reagent or, where indicated, to 100 p.L volume with a mixture of 5 p.L of human plasma in 150 p.L of the Bio-Rad preparation reagent. The eluting solutions, purchased from the manufacturer, are designated as first elution/developing reagent (a low ionic strength borate/phosphate buffer that 'elutes the HbA la and HbA lb and further dissociates the [labile] Schiff base') and a second elution/developing reagent having a higher ionic strength which 'elutes HbA 1e independently' from the remaining haemoglobin fraction. The first and second fractions were collected into I· 5 and 4· 0 mL respectively, according to the procedure described in the package insert. After collection of the second fraction, l : 5 mL of potassium phosphate buffer made 1 mollL in NaCI were applied to the minicolumns to elute remaining haemoglobin. Absorbance in each fraction was read in a spectrophotometer at 415 nm. In initial studies, 100 p.g of HbA la + Ib or of HbA le, or 1 rng of HbA o , each brought to 100 p.L volume with the manufacturer's preparation reagent, were applied to individual columns, and the absorbance in the second fraction was divided by five times the absorbance in a 20 p.L aliquot of the starting haemoglobin solutions diluted into 4 mL of the second eluting reagent. This allowed calculation of the 'per cent HbA le' according to the instructions recovered in the second fraction, and 40% of the applied HbA 1a + lb eluted in this fraction.
RESULTS
The incomplete elution of HbA la + Ib in the first fraction, and of HbA le in the second fraction, was confirmed by examining the absorbance in each elution fraction after separate applications of each of the haemoglobin preparations. Representative elution profiles of HbA la + Ib from the ·20 I'L of starting solution into 4 mL of second elution reagent. "Calculated by dividing absorbance in the second eluting fraction by five times the total absorbance where total is defined according to the above asterisk.
( bl [v/v] added to each litre of buffer; pH titrated to 7'0) and 4% Buffer B (0'12moIlL NaH 1PO.; 10% acetonitrile lv/v] added to each litre of buffer; pH titrated 6· 54) and run at a flow rate of 1·2 mL/min for a total of 16 min. The elution was programmed to change the ratios ofBuffer A to Buffer B from 9614 at time 0 to 70/30 at 5 min, 30/70 at 10 min, and 01100 at 11 min. The integrated areas under the curves in (a), (b) and (c), respectively, represent 99· 0, 98· 5 and 99· 7% of the applied haemoglobin TABLE 2. Elution profile of HbA,Q+,bfrom ion exchange minicolumns. One hundred micrograms of authentic HbA IQ+ 1b was applied (see Fig. I ). The first fraction was collected with the first elution/developing reagent; the second fraction was collected with the second elution/developing reagent; and the I mollL NaClfraction was collected with O'05 mollL potassium phosphate buffer pH 6· 85 containing I mollL NaCl. Absorbance adjusted to I .5 mL volume for the second fraction. In column I, the haemoglobin was applied in 100 p.L preparation reagent; in column 2, the haemoglobin was applied in preparation reagent containing plasma to simulate actual blood samples mini columns are shown in Table 2 . With application of 100 /log in preparation reagent, 420/0 of the sample emerged as expected in the first fraction; 47% and 11% of the applied haemoglobin eluted in the second fraction and in the 1 mollL NaCI wash, respectively (Column 1). Findings were similar when the haemoglobin preparation was brought to volume and conditions simulating those of whole blood samples for application to the minicolumns (Column 2; see Methods). Elution profiles of purified HbA 1c from the mini columns are summarized in Table 3 . About 80% of an applied sample of 100 /log emerged as expected in the second fraction, with negligible amounts escaping into the first fraction (Column 1). Nevertheless, from 15-20% of the HbA lc did not elute in accordance with the specifications provided in the package insert, requiring 1 mollL NaCI to elute from the columns. However, when the HbA 1c was brought to volume in plasmacontaining preparation reagent, about 14% of the applied HbA l c eluted in the first fraction (Column 2). Table 4 shows elution profiles from the minicolumns of purified HbA o , which should not appear in the first or second fraction collections. About 3% of an applied sample of 1 mg of HbA o eluted in the second fraction which, according to the manufacturer, is supposed to represent only HbA l c (Column 1). When HbA o was applied in plasma-containing reagent, larger amounts eluted in the first and second fractions (Column 2).
The foregoing findings were further substantiated by analysing in the HPLC system the haemoglobin in actual patient samples that eluted in the second and third minicolumn fractions. The patient samples were haemolysed, applied to and eluted from the mini columns in accordance with the manufacturers' instructions, and the eluants were dialysed extensively against water, concentrated, and mixed with starting buffer for the HPLC run. Figure 2 illustrates typical HPLC elution profiles of these fractions. The second fraction contained haemoglobin appearing in the A 1a + b position, representing about 60% according to the integrated area under the curve (top panel). HPLC analysis of the third fraction indicated that about 8% of the haemoglobin in this fraction represented HbA 1a + Ib and HbA 1c , and an unidentified peak of about 7%.
DISCUSSION
The early techniques for the separation of minor haemoglobin components were instrumental not only in their identification but also in the development of a system of nomenclature.I-t TABLE 3 . Elution profile of HbA l e from ion exchange minicolumns. One hundred micrograms of authentic HbA lc was applied (see Fig. 1 ). Elution schedules as in Table  2 . In column 1, the HbA l e was applied in 100 p.Lpreparation reagent; in column 2, the HbA Ic was applied in preparation reagent containing plasma (see Methods) . 1 ). Elution schedules as in Table  2 . In column I, the haemoglobin was applied in 100 ul: preparation reagent; in column 2, the haemoglobin was applied in preparation reagent containing plasma . Waters high-performance liquid chromatography (HPLC) analysisof the second (a) and third (b) fractions eluted from an ion exchange minicolumn after application of a patient sample accordingto the manufacturers' instruction. The eluants were dialysed extensively against water before application to the HPLC, which was programmed as in the legend to Fig. 1 Thus, haemoglobins modified at the amino terminus of the fj-chain, which elute earlier than HhA, from ion exchange chromatography because of changes in the isoelectric point, were designated HbA lal , HbA la2, HbA lb and HbA le according to their successive elution profile. Structure analysis confirmed that HbA le contains glucose in keto amine linkage with the N-terminus, making it a favourable candidate for clinical usage to assess diabetic control not only because it represented a glucose-dependent modification but also because it could be separated for measurement from other haemoglobins in electrophoretic or chromatographic systems. Eamino groups of lysine residues along the a-and fj-chains of haemoglobin also are subject to nonenzymatic glycation in vivo, 23, 24 but modification by glucose at these sites does not usually result in changes in electrophoretic or ion exchange chromatographic properties. Non Ale glycohaemoglobin can account for as much or more glucose-modified haemoglobin as HbA 1e 23, 24 but it does not elute in the HbA le fraction from ion exchange chromatography unless it also is glycated at the N-terminal valine site." Thus, elution from ion exchange columns of the purified HbA le used in these experiments should be identical to that of HbA le in clinical samples.
First fraction
The foregoing results demonstrate separatory inadequacy of ion exchange rninicolumns used for measurement of HbA le. Contrary to expectation and to the claims made in the package insert, only about 60070 of the applied HbA le eluted in this fraction when conditions of application simulating those of actual clinical samples were used. Further, under these conditions HbA o significantly contaminated the first and second fraction, which are supposed to contain only HbA 1a + lb and HbA le, respectively. It should be noted that the minicolurnn separations for these experiments were conducted according to the protocol recommended by Bio-Rad in the package insert with respect to sample size, elution schedule and eluting solutions. The protocol dictates application of a 100 JLL aliquot of lysate that is prepared by mixing 100 JLL of whole blood with 1500 JLL of haemolysing reagent. This corresponds with application to the minicolumns of about 1. 0 mg of total haemoglobin (assuming normal haemoglobin of 15 gm/dL). Thus, the amounts of HbA 1a + 1b, Ale and Hb.A; that were applied in these experiments were within range of the (bl (a) 2·25 amounts typically applied in clinical samples. When larger amounts were applied to the minicolumns (e.g. 250 p.g of HbA le or 2·5 mg of HbA o ) the proportional contamination of the third fraction with HbA le or of the second fraction with HbA o was exaggerated. Although such amounts would correspond with exceedingly high haemoglobin concentrations, the results illustrate the limited binding capacity of the resin in the minicolumns, which can be quickly exceeded when the amount of haemoglobin applied deviates above normal concentrations. Since the purpose of the present study was to examine the separatory adequacy of the minicolumns under conditions relevant to clinical samples, we adhered to recommended application amounts, volumes and collection procedures. The reason for the imperfect separation of N-terrninally modified and unmodified haemoglobins on the Bio-Rad minicolumns is unclear, but is presumed to reflect inadequacies of the binding characteristics of the resin, which is a weak cation exchange resin, with respect to given ionic strengths of the eluting buffers. Fluckiger and Woodtli l8 also found imperfect separation, but did not identify the nature of the haemoglobin species appearing in the trailing shoulders. Their estimate that 20% of the HbA le peak was not collected in the Ale fraction, and that the collected fraction for the HbA le included 120/0 of the HbA1a+ lb material, was based on absorbance profiles in the first and second fractions after application of whole blood. The present study demonstrates that the appearance of A la + lbin the Ale fraction is much greater than previously suspected, and that HhA, escapes into both the first and second fractions.
The use of ion exchange minicolumns for estimation of HbA le rests on the assumptions that only HbA lc is eluted with the second elution/ developing reagent, that the first and second elutions are substantially free of HhA; or other haemoglobins, and that all of the HbA le is eluted in the second fraction. These assumptions appear to be incorrect. First, as these results demonstrate, about 40% of HbA 1a + lb and 3-6% of HhA, escapes in the 'HbA1c' fraction. Second, almost 40% of HbA le does not elute in this fraction. This problem was detected by application of highly purified preparations of the different haemoglobin species, but would escape detection with application of mixed (clinical) samples from which various percents of the mixture are eluted in various fractions that are given arbitrary designations but the contents of which are not rigorously analysed. The clinical Ann Clin Biochem 1993: 30 impact of these limitations in the HbA le minicolumn assay requires further study. Even if erroneous, the assay provides a number that the physician can use to assess long-term integrated glycemic control in a patient from one period relative to another and therefore is considered clinically useful. However, this does not speak to the issue of whether the assay actually measures what it says it does, which the present findings question.
